De persberichten worden uitgegeven door FUJIFILM Corporation in Japan.
Fujifilm doet geen toezegging dat de producten die worden vermeld in deze persberichten in alle landen en regio’s commercieel verkrijgbaar zijn.
Houd er rekening mee dat de inhoud van deze website actueel is vanaf de datum van het persbericht en zonder voorafgaande kennisgeving kan worden gewijzigd. Informatie in elk bericht, zoals de beschikbaarheid van het product, specificatie, prijzen, contacten, is actueel op het moment van publicatie.
- apr 5, 2023
- Fujifilm unveils the latest development roadmap for the Duvo series of FUJINON broadcast zoom lenses compatible with large sensors
- mrt 23, 2023
- Fujifilm launches “FUJINON HZK25-1000mm”
- jan 6, 2023
- FUJIFILM Cellular Dynamics Announces License Agreement with Novo Nordisk for the Development of iPSC-Derived Cell Therapies
- dec 13, 2022
- Fujifilm to Build an Advanced Semiconductor Materials Manufacturing Facility in South Korea
- nov 22, 2022
- Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility
- okt 19, 2022
- Fujifilm develops “FUJINON HZK25-1000mm”
- okt 6, 2022
- Fujifilm to establish its first Bio-CDMO site in Japan
- okt 3, 2022
- Fujifilm to establish a local subsidiary in South Korea to accelerate business growth of cell culture media
- sep 8, 2022
- Fujifilm announces a strategic investment in a new production facility in Kumamoto Japan to support the fast-growing semiconductor industry
- jul 6, 2022
- Fujifilm launches FUJIFILM PROJECTOR Z6000
- jul 1, 2022
- Fujifilm launches world’s first mobile app “FUJIFILM Prescale Mobile” that quantifies pressure based on color development on pressure measurement film
- jun 30, 2022
- Fujifilm to Invest USD 1.6 billion to enhance and expand its global offering of cell culture manufacturing services
- jun 8, 2022
- Fujifilm Acquires European Inkjet System Integrator UNIGRAPHICA to Expand Inkjet Integration Business Globally
- apr 5, 2022
- Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
- mrt 29, 2022
- Fujifilm Completes Acquisition of Shenandoah Biotechnology
- mrt 28, 2022
- Fujifilm Invests in a new manufacturing facility for inkjet pigment dispersions in the U.S.
- mrt 23, 2022
- Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinant Proteins
- jan 26, 2022
- Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
- dec 8, 2021
- Fujifilm Kicks Off Operations at its New, State-of-the-Art Cell Culture Media Manufacturing Facility in Europe
- dec 1, 2021
- FUJIFILM Irvine Scientific Establishes a Bioprocessing Innovation and Collaboration Center in China (FUJIFILM Irvine Scientific)